Clinical Pharmacology in Drug Development: A randomized Phase 1 evaluation of deupirfenidone, a novel deuterium-containing drug candidate for interstitial lung disease and other inflammatory and fibrotic diseases
Clinical Pharmacology in Drug Development: A randomized Phase 1 evaluation of deupirfenidone, a novel deuterium-containing drug candidate for interstitial lung disease and other inflammatory and fibrotic diseases
2021-11-15